Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 390-396

  Nihei, Keiji ^a   Ogino, Takashi ^a   Onozawa, Masakatsu ^a   Murayama, Shigeyuki ^b   Fuji, Hiroshi ^b   Murakami, Masao ^c   Hishikawa, Yoshio ^c  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

^c HYOGO ION BEAM MEDICAL CENTER   (Japan)

Author keywords

Clinical trial; Prostate cancer; Proton beam therapy; Radiotherapy; Rectal toxicity

Indexed keywords

ANTIGENS; DISEASES; PROTON BEAMS; RADIOTHERAPY; TELEMEDICINE; TOXICITY; UROLOGY;

CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; INSTITUTIONAL REVIEW BOARDS; LOCALIZED PROSTATE CANCER; NATIONAL CANCER INSTITUTE; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RECTAL TOXICITY;

PROTON BEAM THERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLADDER DISEASE; CANCER HORMONE THERAPY; CANCER STAGING; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RECTUM DISEASE; REVIEW;

EID: 80052811777     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.027     Document Type: Article

References (30)

1. C.A. Perez, B.J. Walz, and F.R. Zivnuska Irradiation of carcinoma of the prostate localized to the pelvis: Analysis of tumor response and prognosis Int J Radiat Oncol Biol Phys 6 1980 555 563 (Pubitemid 10065003)
2. G.E. Hanks, K.L. Martz, and J.J. Diamond The effect of dose on local control of prostate cancer Int J Radiat Oncol Biol Phys 15 1988 1299 1305 (Pubitemid 19015470)
3. P.A. Kupelian, M. Elshaikh, and C.A. Reddy Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: A large single-institution experience with radical prostatectomy and external-beam radiotherapy J Clin Oncol 20 2002 3376 3385
4. M.V. Pilepich, J.M. Krall, and W.T. Sause Prognostic factors in carcinoma of the prostate - Analysis of RTOG study 75-06 Int J Radiat Oncol Biol Phys 13 1987 339 349 (Pubitemid 17053946)
5. G.E. Hanks External-beam radiation therapy for clinically localized prostate cancer: Patterns of care studies in the United States NCI Monogr 7 1988 75 84
6. J.M. Michalski, K. Bae, and M. Roach Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22
7. O. Cahlon, M. Hunt, and M.J. Zelefsky Intensity-modulated radiation therapy: Supportive data for prostate cancer Semin Radiat Oncol 18 2008 48 57 (Pubitemid 350235956)
8. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129 (Pubitemid 351296130)
9. M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415 1419 (Pubitemid 44307191)
10. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix consensus conference Int J Radiat Oncol Biol Phys 65 2006 965 974
11. H. Thames, D. Kuban, and L. Levy Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995 Int J Radiat Oncol Biol Phys 57 2003 929 943 (Pubitemid 37324110)
12. M.J. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116 (Pubitemid 34787844)
13. J.M. Michalski, J.A. Purdy, and K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402 (Pubitemid 30067789)
14. J.K. Ryu, K. Winter, and J.M. Michalski Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) Int J Radiat Oncol Biol Phys 54 2002 1036 1046 (Pubitemid 35292614)
15. J.M. Michalski, K. Winter, and J.A. Purdy Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose level I and II Int J Radiat Oncol Biol Phys 56 2003 192 198 (Pubitemid 36403691)
16. A. Pollack, G.K. Zagars, and Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
17. K. Nihei, T. Ogino, and S. Ishikura Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: First clinical trial of proton beam therapy for prostate cancer in Japan Jpn J Clin Oncol 35 2005 745 752 (Pubitemid 43091660)
18. J.M. Michalski, K. Winter, and J.A. Purdy Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406 Semin Radiat Oncol 12 Suppl. 1 2002 75 80 (Pubitemid 34246073)
19. T.N. Eade, E.M. Horwitz, and K. Ruth A Comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or I 125 permanent implant Int J Radiat Oncol Biol Phys 71 2008 338 345
20. G.O. De Meerleer, V.H. Fonteyne, and L. Vakaet Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control Radiother Oncol 82 2007 160 166
21. S.A. Vora, W.W. Wong, and S.E. Schild Analysis of biochemical control and prognostic factors in patients treated with either low-dose three dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 68 2007 1053 1058 (Pubitemid 47048576)
22. J.D. Slater, L.T. Yonemoto, and C.J. Rossi Jr. Conformal proton therapy for prostate cancer Int J Radiat Oncol Biol Phys 42 1998 299 304 (Pubitemid 28502775)
23. K. Nihei, T. Nishio, and S. Ishikura Analysis of dose volume histograms in proton therapy for prostate cancer (ECCO [European Cancer Organisation] 12 Abstract Book) Eur J Cancer Suppl 1 2003 S161 S162
24. P.A. Kupelian, C.A. Reddy, and E.A. Klein Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life Int J Radiat Oncol Biol Phys 51 2001 988 993 (Pubitemid 33026429)
25. C. Fiorino, C. Cozzarini, and V. Vavassori Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions Radiother Oncol 64 2002 1 12 (Pubitemid 35223147)
26. J.F. Fowler, M.A. Ritter, and R.J. Chappell What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56 2003 1093 1104 (Pubitemid 36794043)
27. P.A. Kupelian, V.V. Thakkar, and D. Khuntia Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes Int J Radiat Oncol Biol Phys 63 2005 1463 1468 (Pubitemid 41628043)
28. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1240
29. B.G. Gardner, A.L. Zeitman, and W.U. Shipley Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123 126 (Pubitemid 34024514)
30. C.A. Lawton, K. Bae, and M. Pilepich Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: Analysis of Radiation Therapy Oncology Group studies 85-31, 86-10, and 92-02 Int J Radiat Oncol Biol Phys 70 2008 437 441